We are live on ! Find out more
NA

Navellier & Associates Portfolio holdings

AUM $960M
1-Year Est. Return 79.37%
This Fund
S&P 500
This Quarter Est. Return
+10.97%
1 Year Est. Return
+79.37%
3 Year Est. Return
+262.34%
5 Year Est. Return
+412.53%
10 Year Est. Return
+2,309.54%
AUM
$2B
AUM Growth
+$12.2M
Cap. Flow
-$123M
Cap. Flow %
-6.13%
Top 10 Hldgs %
36.44%
Holding
384
New
60
Increased
76
Reduced
187
Closed
58

Top Buys

Rank Stock Value
1
HNT
HEALTH NET INC
HNT
+$39.4M
2
HPQ icon
HP
HPQ
+$34M
3
SO icon
Southern Company
SO
+$33.9M
4
CNC icon
Centene
CNC
+$33.7M
5
UGI icon
UGI
UGI
+$33M

Sector Composition

Rank Sector Weight
1 Healthcare 30.15%
2 Technology 21.65%
3 Industrials 12.91%
4 Utilities 10.27%
5 Consumer Staples 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACN icon
251
Accenture
ACN
$102B
$303K 0.02%
3,398
-27
-0.8% -$2.24K
RIO icon
252
Rio Tinto
RIO
$158B
$302K 0.02%
6,553
-100
-2% -$4.71K
FISV
253
Fiserv Inc
FISV
$28.8B
$298K 0.01%
8,400
-600
-7% -$20.5K
HRI icon
254
Herc Holdings
HRI
$5.02B
$298K 0.01%
3,989
-33
-0.8% -$2.23K
TSEM icon
255
Tower Semiconductor
TSEM
$24.8B
$297K 0.01%
+22,300
New +$250K
CWB icon
256
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.6B
$295K 0.01%
6,287
+208
+3% +$10.2K
STR
257
DELISTED
QUESTAR CORP
STR
$294K 0.01%
11,637
-95
-0.8% -$2.27K
POZN
258
DELISTED
POZEN INC
POZN
$290K 0.01%
36,200
+21,500
+146% +$185K
ADP icon
259
Automatic Data Processing
ADP
$106B
$283K 0.01%
3,400
-8,768
-72% -$711K
ASML icon
260
ASML
ASML
$626B
$278K 0.01%
2,579
-23
-0.9% -$2.33K
NMR icon
261
Nomura Holdings
NMR
$28.3B
$273K 0.01%
48,131
-2,138
-4% -$12.7K
SMG icon
262
ScottsMiracle-Gro
SMG
$3.82B
$273K 0.01%
4,378
-20
-0.5% -$1.19K
AZN icon
263
AstraZeneca
AZN
$263B
$272K 0.01%
3,859
-28
-0.7% -$2K
PGX icon
264
Invesco Preferred ETF
PGX
$3.81B
$271K 0.01%
18,463
-76
-0.4% -$1.11K
RTN
265
DELISTED
Raytheon Company
RTN
$271K 0.01%
2,501
-172
-6% -$17.8K
ARMH
266
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$271K 0.01%
5,852
-58
-1% -$2.48K
CMCSA icon
267
Comcast
CMCSA
$85B
$265K 0.01%
9,130
-2,500
-21% -$68.5K
KUB
268
DELISTED
KUBOTA CORPORATION (ONE ADS REP 5 SHS COM)
KUB
$263K 0.01%
3,581
-30
-0.8% -$2.2K
CLX icon
269
Clorox
CLX
$11.6B
$258K 0.01%
2,479
-8
-0.3% -$800
BNL
270
DELISTED
BUNZL PLC ADS (RP 5 ORD SHS)
BNL
$258K 0.01%
9,383
-98
-1% -$2.69K
WEC icon
271
WEC Energy
WEC
$35.7B
$257K 0.01%
4,871
-18
-0.4% -$883
TEP
272
DELISTED
Tallgrass Energy Partners, LP
TEP
$252K 0.01%
+5,633
New +$237K
SEE
273
DELISTED
Sealed Air
SEE
$251K 0.01%
5,915
-48
-0.8% -$1.8K
MFG icon
274
Mizuho Financial
MFG
$127B
$245K 0.01%
72,049
-2,661
-4% -$9.27K
DD icon
275
DuPont de Nemours
DD
$18.5B
$243K 0.01%
2,103
-256,452
-99% -$31.3M

Similar funds

Navellier & Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Navellier & Associates held 384 positions worth $2B, up 0.62% from $1.99B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Navellier & Associates withdrew a net $123M in Q4 2014, closing 58 positions and reducing 187 holdings. Its most notable exit was Thermo Fisher Scientific, an estimated $71.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Technology and Industrials.

Against the trend, Navellier & Associates opened a new position in HEALTH NET INC worth $42.8M.

  • Navellier & Associates's largest Q4 2014 buy was HEALTH NET INC: 799,779 shares worth $42.8M.
  • Navellier & Associates added most to Southern Company in Q4 2014, an estimated $33.9M increase.
  • Navellier & Associates's biggest Q4 2014 reduction was DuPont de Nemours, cutting an estimated $31.3M.
  • Navellier & Associates fully exited Thermo Fisher Scientific in Q4 2014, selling an estimated $71.9M.
  • Navellier & Associates's ten largest holdings make up 36% of its $2B portfolio in Q4 2014.
  • Navellier & Associates opened 60 new positions and closed 58 in Q4 2014.
  • Navellier & Associates's portfolio value rose 0.62% quarter-over-quarter to $2B.

Based on Navellier & Associates's 13F filing for Q4 2014, filed 2 Feb 2015.